Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
18,810,702
-
Total 13F shares
-
21,129,287
-
Share change
-
-27,542
-
Total reported value
-
$1,773,183,030
-
Put/Call ratio
-
133%
-
Price per share
-
$83.90
-
Number of holders
-
284
-
Value change
-
-$3,874,532
-
Number of buys
-
126
-
Number of sells
-
163
Institutional Holders of LEMAITRE VASCULAR INC - Common Stock (LMAT) as of Q1 2025
As of 31 Mar 2025,
LEMAITRE VASCULAR INC - Common Stock (LMAT) was held by
284 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
21,129,287 shares.
The largest 10 holders included
BlackRock, Inc., Conestoga Capital Advisors, LLC, VANGUARD GROUP INC, Copeland Capital Management, LLC, GENEVA CAPITAL MANAGEMENT LLC, STATE STREET CORP, CONGRESS ASSET MANAGEMENT CO, Ranger Investment Management, L.P., GEODE CAPITAL MANAGEMENT, LLC, and DIMENSIONAL FUND ADVISORS LP.
This page lists
286
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.